Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Quinolone Antimicrobial [EPC]
Ofloxacin is a potent, second-generation fluoroquinolone antibiotic used to treat various bacterial infections, including those of the respiratory tract, skin, and urinary system, by inhibiting bacterial DNA replication.
Name
Ofloxacin
Raw Name
OFLOXACIN
Category
Quinolone Antimicrobial [EPC]
Drug Count
9
Variant Count
87
Last Verified
February 17, 2026
RxCUI
242446, 312075, 198048, 198049, 198050, 207202
UNII
A4P49JAZ9H
About Ofloxacin
Ofloxacin is a potent, second-generation fluoroquinolone antibiotic used to treat various bacterial infections, including those of the respiratory tract, skin, and urinary system, by inhibiting bacterial DNA replication.
Detailed information about Ofloxacin
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Ofloxacin.
Pharmacologically, Ofloxacin is classified as a Quinolone Antimicrobial [EPC]. It is distinguished from earlier quinolones (like nalidixic acid) by the addition of a fluorine atom at the 6-position and a methyl-substituted oxazine ring, which significantly enhances its antibacterial potency and broadens its spectrum of activity. While the systemic (oral and intravenous) forms have been largely superseded by newer-generation fluoroquinolones in some regions, Ofloxacin remains a critical therapeutic option in various clinical settings, particularly in its ophthalmic (eye) and otic (ear) formulations.
Ofloxacin exerts its bactericidal (bacteria-killing) effect by interfering with the essential processes of bacterial DNA replication, transcription, repair, and recombination. At the molecular level, Ofloxacin targets two primary enzymes within the bacterial cell: DNA gyrase (also known as Topoisomerase II) and Topoisomerase IV. These enzymes are crucial for managing the physical structure of DNA during the replication process.
Because human cells use a different type of topoisomerase (Topoisomerase II) that is structurally distinct and much less sensitive to quinolones, Ofloxacin demonstrates selective toxicity toward bacterial cells, leaving human DNA replication largely unaffected at therapeutic concentrations.
Understanding the pharmacokinetics of Ofloxacin is essential for optimizing clinical outcomes and minimizing toxicity. The drug is characterized by high bioavailability and excellent tissue penetration.
Ofloxacin is FDA-approved for the treatment of several mild-to-moderate infections caused by susceptible strains of microorganisms. These include:
Ofloxacin is available in multiple delivery formats to target specific infection sites:
> Important: Only your healthcare provider can determine if Ofloxacin is right for your specific condition. The choice of antibiotic depends on the suspected pathogen, local resistance patterns, and your individual health history.
The dosage of Ofloxacin varies significantly based on the type and severity of the infection being treated. Standard adult oral dosages typically range from 200 mg to 400 mg every 12 hours. Below are common dosing regimens according to FDA-approved labeling:
Ofloxacin is generally NOT approved for use in pediatric patients under the age of 18. This restriction is due to observations in animal studies where fluoroquinolones caused arthropathy (joint disease) and permanent damage to the cartilage of weight-bearing joints. While healthcare providers may occasionally use Ofloxacin off-label in children for specific, life-threatening infections where no other alternatives exist (such as certain cases of cystic fibrosis or multidrug-resistant infections), this is done only under extreme caution and expert supervision.
Because Ofloxacin is primarily eliminated by the kidneys, dosage adjustments are mandatory for patients with decreased renal function to prevent drug accumulation and toxicity. According to the manufacturer's guidelines:
In patients with severe hepatic impairment (e.g., cirrhosis with ascites), the maximum daily dose should not exceed 400 mg, as the clearance of the drug may be reduced.
No specific dosage adjustment is usually required based solely on age; however, because elderly patients are more likely to have decreased renal function, their dosage should be based on their calculated creatinine clearance. Additionally, elderly patients are at a higher risk for tendon rupture and aortic aneurysm while taking Ofloxacin.
To ensure maximum efficacy and safety, patients should follow these administration guidelines:
If you miss a dose of Ofloxacin, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of side effects.
Signs of an Ofloxacin overdose may include severe dizziness, nausea, vomiting, facial swelling, numbness, tingling, or seizures. In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is generally supportive, including gastric lavage and maintaining adequate hydration.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance.
While Ofloxacin is generally well-tolerated, some patients may experience mild to moderate side effects. The most frequently reported adverse reactions include:
> Warning: Stop taking Ofloxacin and call your doctor immediately if you experience any of the following serious symptoms:
Prolonged or repeated use of Ofloxacin can lead to 'superinfections,' such as oral thrush or vaginal yeast infections, due to the overgrowth of non-susceptible organisms. Additionally, the FDA has warned about 'Fluoroquinolone-Associated Disability' (FQAD), where some patients experience long-lasting or permanent side effects involving the tendons, muscles, joints, and nervous system simultaneously.
Ofloxacin carries the FDA's most serious 'Black Box Warning' due to the risk of several disabling and potentially irreversible adverse reactions:
Report any unusual symptoms to your healthcare provider immediately. Early intervention is key to preventing long-term complications.
Ofloxacin is a potent antibiotic that must be used with caution. It is reserved for infections that cannot be treated with safer alternatives, especially for uncomplicated conditions like acute bronchitis or simple urinary tract infections, due to the risk of serious side effects.
As of the latest FDA updates (2024), Ofloxacin contains a boxed warning stating that fluoroquinolones are associated with disabling and potentially irreversible serious adverse reactions that may occur together. These include tendonitis and tendon rupture, peripheral neuropathy, and central nervous system effects. If a patient experiences any of these symptoms, Ofloxacin must be discontinued immediately, and the patient should avoid future use of any fluoroquinolone.
Healthcare providers may order the following tests while you are on Ofloxacin:
Ofloxacin may cause dizziness, lightheadedness, or somnolence. Patients should observe how they react to the medication before driving, operating heavy machinery, or engaging in activities requiring mental alertness.
While alcohol does not have a direct chemical interaction with Ofloxacin, it is generally advised to avoid alcohol during any infection. Alcohol can impair the immune system, cause dehydration, and worsen CNS side effects like dizziness or nausea.
Do not stop taking Ofloxacin mid-course unless instructed by a doctor due to a serious side effect. Abruptly stopping an antibiotic for an active infection can lead to treatment failure and the development of antibiotic-resistant bacteria.
> Important: Discuss all your medical conditions, including any history of heart rhythm problems, kidney disease, or joint issues, with your healthcare provider before starting Ofloxacin.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication review is necessary to prevent dangerous interactions.
Ofloxacin must NEVER be used in the following circumstances:
Healthcare providers must perform a careful risk-benefit analysis in patients with:
There is a high degree of cross-sensitivity among members of the quinolone class. If a patient has had a severe reaction to one quinolone, they should be considered allergic to all others, including Ofloxacin, unless otherwise determined by an allergist.
> Important: Your healthcare provider will evaluate your complete medical history, including any rare genetic conditions or past reactions to antibiotics, before prescribing Ofloxacin.
Ofloxacin is classified as Pregnancy Category C. Data from animal studies have shown that Ofloxacin can cause arthropathy and bone growth issues in developing fetuses. There are no adequate and well-controlled studies in pregnant women. Ofloxacin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is generally avoided, especially during the first trimester, in favor of safer alternatives like penicillins or cephalosporins.
Ofloxacin is excreted in human breast milk. Because of the potential for serious adverse reactions in nursing infants (including the risk of joint damage), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. If Ofloxacin must be used, some experts suggest waiting 4 to 6 hours after a dose before breastfeeding to minimize infant exposure.
Safety and effectiveness in pediatric patients and adolescents under the age of 18 years have not been established. The primary concern is the potential for permanent damage to weight-bearing joints (arthropathy). Use in children is restricted to exceptional cases where no other effective antibiotic is available.
Elderly patients (aged 65 and older) are at increased risk for several severe adverse effects:
In patients with a creatinine clearance of less than 50 mL/min, the dosage of Ofloxacin must be reduced. Failure to adjust the dose can lead to toxic accumulations of the drug, increasing the risk of seizures and other CNS disturbances. Ofloxacin is not efficiently removed by hemodialysis or peritoneal dialysis.
In patients with severe liver dysfunction (e.g., Child-Pugh Class C), the clearance of Ofloxacin may be reduced, and the half-life prolonged. A maximum daily dose of 400 mg is recommended for these patients to prevent adverse effects.
> Important: Special populations require individualized medical assessment and frequent monitoring by a healthcare professional.
Ofloxacin is a bactericidal agent that inhibits bacterial DNA synthesis. It targets two essential enzymes: DNA gyrase, which relaxes positive supercoils to allow DNA replication, and Topoisomerase IV, which is responsible for separating daughter DNA strands. By forming a stable complex with these enzymes and the bacterial DNA, Ofloxacin creates physical barriers that lead to permanent DNA breaks. This stops the bacteria from replicating and results in cell death. Its activity is concentration-dependent, meaning its effectiveness is linked to the peak concentration reached at the site of infection.
The efficacy of Ofloxacin is best predicted by the ratio of the Area Under the Curve (AUC) to the Minimum Inhibitory Concentration (MIC). For Gram-negative pathogens, an AUC/MIC ratio of 100-125 is typically targeted, while for Gram-positive pathogens, a ratio of 30-40 is often sufficient. Ofloxacin also exhibits a Post-Antibiotic Effect (PAE), where bacterial growth continues to be suppressed even after the drug concentration falls below the MIC.
| Parameter | Value |
|---|---|
| Bioavailability | 95% - 100% |
| Protein Binding | 20% - 32% |
| Half-life | 4 - 9 hours |
| Tmax | 1 - 2 hours |
| Metabolism | Minimal (<5% hepatic) |
| Excretion | Renal 70-80%, Fecal <5% |
Ofloxacin belongs to the Fluoroquinolone class of antibiotics. It is specifically a second-generation quinolone, providing better Gram-negative coverage than first-generation drugs and improved systemic absorption. It is closely related to levofloxacin, which is the S-enantiomer of ofloxacin and is roughly twice as potent.
Medications containing this ingredient
Common questions about Ofloxacin
Ofloxacin is a broad-spectrum antibiotic used to treat a variety of bacterial infections in adults. It is commonly prescribed for urinary tract infections (UTIs), chronic prostatitis, and lower respiratory tract infections like pneumonia or bronchitis. It is also effective against certain skin infections and sexually transmitted diseases such as chlamydia. However, due to the risk of serious side effects, the FDA recommends reserving Ofloxacin for infections that cannot be treated with other safer antibiotics. It is only effective against bacterial infections and will not work for viral infections like the common cold or flu.
The most frequently reported side effects of Ofloxacin include nausea, headache, insomnia, and dizziness. Some patients may also experience diarrhea or abdominal pain during treatment. In women, Ofloxacin can sometimes lead to vaginal yeast infections due to changes in the body's natural bacterial balance. While these common side effects are usually mild, it is important to monitor them closely. If you experience severe diarrhea, persistent vomiting, or any signs of an allergic reaction, you should contact your healthcare provider immediately.
There is no direct chemical interaction between Ofloxacin and alcohol that makes it strictly forbidden; however, healthcare providers generally recommend avoiding alcohol while fighting an infection. Alcohol can dehydrate the body and weaken the immune system, potentially slowing down your recovery. Furthermore, both alcohol and Ofloxacin can cause dizziness and lightheadedness, so combining them may increase the risk of falls or accidents. To ensure your body can focus entirely on healing, it is best to abstain from alcohol until you have finished your antibiotic course and feel fully recovered.
Ofloxacin is generally not recommended during pregnancy unless the potential benefits clearly outweigh the risks. It is classified as FDA Pregnancy Category C, meaning animal studies have shown potential harm to the developing fetus, specifically regarding bone and joint development. There is a concern that fluoroquinolones could cause cartilage damage in the unborn baby. If you are pregnant or planning to become pregnant, your doctor will likely prescribe a different class of antibiotics, such as a penicillin or cephalosporin, which have a longer track record of safety during pregnancy. Always inform your doctor if you discover you are pregnant while taking this medication.
Most patients begin to feel an improvement in their symptoms within 48 to 72 hours of starting Ofloxacin. However, the exact time frame depends on the type and severity of the infection being treated. For example, a simple urinary tract infection may show improvement faster than a deep-seated lung infection or chronic prostatitis. Even if you feel significantly better after just a few doses, it is absolutely critical to complete the entire course of treatment as prescribed. Stopping the medication early can allow the remaining bacteria to multiply, leading to a relapse of the infection and contributing to the global problem of antibiotic resistance.
You should not stop taking Ofloxacin suddenly unless you experience a serious adverse reaction, such as tendon pain, nerve tingling, or a severe allergic reaction. If you stop the medication prematurely because you feel better, the infection may not be fully eradicated, increasing the risk that it will return even stronger. Furthermore, incomplete treatment allows bacteria to develop resistance to the drug, making future infections much harder to treat. If you are experiencing bothersome but non-serious side effects, consult your doctor before making any changes to your regimen. They may be able to offer advice on managing side effects or switch you to a different medication.
If you miss a dose of Ofloxacin, take it as soon as you remember to maintain consistent levels of the antibiotic in your system. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Never take two doses at once to make up for a missed one, as this can increase the concentration of the drug in your blood to dangerous levels and raise the risk of side effects like seizures or heart rhythm issues. Setting a daily alarm or using a pill organizer can help you stay on track with your antibiotic schedule.
Weight gain is not a typical or documented side effect of Ofloxacin. Most side effects related to this medication involve the digestive system (like nausea or diarrhea) or the nervous system (like headache or dizziness). If you notice rapid or unusual weight gain while taking Ofloxacin, it is more likely related to other factors, such as fluid retention or a separate underlying medical condition. In some cases, severe allergic reactions can cause swelling (edema) which might be perceived as weight gain. Always report sudden changes in weight or significant swelling to your healthcare provider for further evaluation.
Ofloxacin has several significant drug interactions that require careful management. It should not be taken at the same time as antacids, multivitamins, or supplements containing iron, calcium, magnesium, or zinc, as these can block the absorption of the antibiotic. It can also increase the levels of other drugs in your system, such as theophylline (for asthma) or warfarin (a blood thinner), potentially leading to toxicity. Additionally, taking Ofloxacin with NSAIDs like ibuprofen can increase the risk of seizures. Always provide your doctor and pharmacist with a complete list of all medications and supplements you are currently taking to avoid dangerous interactions.
Yes, Ofloxacin is widely available as a generic medication in several forms, including oral tablets, ophthalmic (eye) drops, and otic (ear) drops. The brand-name version, Floxin, has been discontinued in the United States, but the generic versions are therapeutically equivalent and usually more cost-effective for patients. Generic Ofloxacin undergoes rigorous testing by regulatory agencies to ensure it has the same active ingredient, strength, and efficacy as the original brand-name drug. Most insurance plans cover the generic version of Ofloxacin, making it an accessible option for treating susceptible bacterial infections.